Download PDF
Frauenheilkunde up2date 2018; 12(04): 343-355
DOI: 10.1055/a-0586-2580
Allgemeine Gynäkologie
Georg Thieme Verlag KG Stuttgart · New York

Benigne Veränderungen der Vulva

Simone K. Renner
,
Matthias W. Beckmann
,
Pia Abel
,
Martin C. Koch
,
Stefan P. Renner
Further Information

Publication History

Publication Date:
12 September 2018 (online)

Also available at
    Permissions and Reprints All articles of this category

Die gynäkologische Untersuchung des gesamten Anogenitalbereichs ist zentraler Bestandteil der Krebsfrüherkennung der Frau. Hierbei ist das Erkennen von gutartigen Veränderungen im Vulvabereich und vor allem die Abgrenzung zu suspekten und bösartigen Veränderungen essenziell, um Übertherapien, aber auch unnötige Sorgen und Ängste bei den betroffenen Frauen zu vermeiden.
Kernaussagen

  • Eine gründliche Anamnese ist essenziell, um zur richtigen Diagnose zu gelangen.

  • Unklare und suspekte Befunde der Vulva müssen histologisch abgeklärt werden.

  • Viele benigne Vulvaerkrankungen sind Blickdiagnosen.

  • Der Lichen sclerosus der Vulva ist häufig unterdiagnostiziert.

  • Das Wissen um Differenzialdiagnosen erleichtert es, die richtige Diagnose zu stellen.

Schlüsselwörter

Vulva - Lichen sclerosus - Vulvitis - HPV - Kondylome - Mykosen
 

  • Literatur

  • 1 Wood SC. Clinical manifestations and therapeutic management of vulvar cellulitis and abscess: Methicillin-resistant Staphylococcus aureus, necrotizing fasciitis, Bartholin abscess, Crohn Disease of the vulva, hidradenitis suppurativa. Clin Obstet Gynecol 2015; 58: 503-511
    CrossrefPubMedGoogle Scholar
  • 2 Mayeaux jr. EJ, Cooper D. Vulvar procedures: biopsy, bartholin abscess treatment, and condyloma treatment. Obstet Gynecol Clin North Am 2013; 40: 759-772
    CrossrefPubMedGoogle Scholar
  • 3 Heller DS, Bean S. Lesions of the Bartholin gland: a review. J Low Genit Tract Dis 2014; 18: 351-357
    CrossrefPubMedGoogle Scholar
  • 4 Sauerbrei A. Herpes Genitalis: Diagnosis, Treatment and Prevention. Geburtshilfe Frauenheilkd 2016; 76: 1310-1317
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Zhai L, Tumban E. Gardasil-9: A global survey of projected efficacy. Antiviral Res 2016; 130: 101-109
    CrossrefPubMedGoogle Scholar
  • 6 Rudy SJ. Imiquimod (Aldara): modifying the immune response. Dermatol Nurs 2002; 14: 268-270
    PubMedGoogle Scholar
  • 7 Cox JT. Extensive condyloma acuminata treated with imiquimod 5 % cream: a case report. Clin Exp Dermatol 2003; 28 (Suppl. 01) 51-54
    CrossrefPubMedGoogle Scholar
  • 8 Sinha S, Relhan V, Garg VK. Immunomodulators in warts: Unexplored or ineffective?. Indian J Dermatol 2015; 60: 118-129
    CrossrefPubMedGoogle Scholar
  • 9 Santorelli C, Leo CA, Baldelli F. et al. Response to imiquimod 5 % cream as treatment for condyloma and anal intraepithelial neoplasia in HIV-positive and HIV-negative patients. Sex Transm Infect 2017; 93: 229
    PubMedGoogle Scholar
  • 10 Hanna E, Abadi R, Abbas O. Imiquimod in dermatology: an overview. Int J Dermatol 2016; 55: 831-844
    CrossrefPubMedGoogle Scholar
  • 11 Takahashi S, Tsukamoto T. [Condyloma acuminatum]. Nihon Rinsho 2009; 67: 153-156
    PubMedGoogle Scholar
  • 12 Tawada C, Oshitani Y, Kimura M. et al. Successful treatment of anal and perianal condyloma acuminata with imiquimod. Acta Derm Venereol 2014; 94: 118-119
    Google Scholar
  • 13 Abramovit W, Gupta AK. Veregen (sinecatechins ointment) 15 %. Skinmed 2010; 8: 46-49
    PubMedGoogle Scholar
  • 14 Hassanain E, Silverberg JI, Norowitz KB. et al. Green tea (Camellia sinensis) suppresses B cell production of IgE without inducing apoptosis. Ann Clin Lab Sci 2010; 40: 135-143
    PubMedGoogle Scholar
  • 15 Spinu D, Radulescu A, Bratu O. et al. Giant condyloma acuminatum – Buschke-Lowenstein disease – a literature review. Chirurgia (Bucur) 2014; 109: 445-450
    Google Scholar
  • 16 Sharma N, Sharma S, Singhal C. A comparative study of liquid nitrogen cryotherapy as monotherapy versus in combination with podophyllin in the treatment of condyloma acuminata. J Clin Diagn Res 2017; 11: WC01-WC05
    CrossrefPubMedGoogle Scholar
  • 17 Mistrangelo M, Cornaglia S, Pizzio M. et al. Immunostimulation to reduce recurrence after surgery for anal condyloma acuminata: a prospective randomized controlled trial. Colorectal Dis 2010; 12: 799-803
    Google Scholar
  • 18 Stock I. [Fungal diseases of vulva and vagina caused by Candida species]. Med Monatsschr Pharm 2010; 33: 324-333 quiz 335–326
    PubMedGoogle Scholar
  • 19 Donders G, Ausma J, Wouters L. et al. Efficacy of a single oral dose of 200 mg pramiconazole in vulvovaginal yeast infections: an exploratory phase II a trial. Acta Derm Venereol 2008; 88: 462-466
    Google Scholar
  • 20 Blostein F, Levin-Sparenberg E, Wagner J, Foxman B. Recurrent vulvovaginal candidiasis. Ann Epidemiol 2017; 27: 575-582.e3
    CrossrefPubMedGoogle Scholar
  • 21 Chew SY, Than LT. Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches. Mycoses 2016; 59: 262-273
    CrossrefPubMedGoogle Scholar
  • 22 Bala V, Chhonker YS. Recent developments in anti-Trichomonas research: An update review. Eur J Med Chem 2018; 143: 232-243
    CrossrefPubMedGoogle Scholar
  • 23 Kirtschig G, Cooper S, Aberer W. et al. Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. J Eur Acad Dermatol Venereol 2017; 31: e81-e83
    CrossrefPubMedGoogle Scholar